NCT07605221 Nomogram for Astigmatism Correction of KLEx
| NCT ID | NCT07605221 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tianjin Eye Hospital |
| Condition | Astigmatism |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-02-18 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-02-18 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if nomogram could promote treatment outcomes in astigmatism correction. The main question it aims to answer is: does the nomogram could promote treatment outcomes in astigmatism correction? If there is a comparison group: Researchers will compare non-nomogram adopted to see if the outcome acceptable. Participants will ask to complete 3-month follow-up of manifest refraction and visual acuity test.
Eligibility Criteria
Inclusion Criteria: * age ≥18 years; preoperative sphere -0.50 D to -10.00 D; preoperative cylinder -1.50 D to -5.00 D; stable refraction (±0.50 D) for 1 year; normal corneal topography; central corneal thickness \>500 μm or predicted residual stromal bed \>280 μm; intraocular pressure \<21 mmHg Exclusion Criteria: * ocular or systematic disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07605221 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Astigmatism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07605221 currently recruiting?
Yes, NCT07605221 is actively recruiting participants. Contact the research team at jiamei3536@163.com for enrollment information.
Where is the NCT07605221 trial being conducted?
This trial is being conducted at Tianjin, China.
Who is sponsoring the NCT07605221 clinical trial?
NCT07605221 is sponsored by Tianjin Eye Hospital. The trial plans to enroll 100 participants.